Cerecin Pte.

BiotechnologySeries BSingapore, Singaporecerecin.com

Latest round

Series B

Last raised

Aug 2022

Total raised

$107M

Investors

15

About Cerecin Pte.

Cerecin Pte. Ltd.Founded in 2001 and headquartered in Singapore, Cerecin Pte. Ltd. specializes in healthcare solutions targeting brain health.Cerecin Neurosciences specializes in innovative healthcare solutions focused on brain health, primarily leveraging the physiological ketone system to provide energy for the brain. Their core product offerings include tricaprilin, which is under investigation in the Phase 3 ALTER AD clinical trial aimed at treating mild to moderate Alzheimer's disease, as well as CER-0001, a ketogenic investigational agent targeting migraine treatment. These products are designed to address significant unmet medical needs in neurological disorders, catering to both patients suffering from these conditions and healthcare providers seeking effective treatment options.Cerecin Neurosciences generated revenue of USD 8,603,671 in 2023, with an EBITDA of USD 3,320,310. The company operates on a B2B model, partnering with healthcare providers and research institutions to advance their therapeutic pipelines.In August 2022, Cerecin Pte. Ltd. The company plans to introduce new products aimed at treating neurological disorders and expand into new markets, specifically targeting regions across Asia and beyond. These initiatives demonstrate Cerecin's commitment to enhancing its therapeutic offerings and addressing emerging global health challenges.

Who invested in Cerecin Pte.

15 investors across 6 rounds

See all investors in Cerecin Pte.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 3, 2022

    Amount

    $7.2M

    Investors

    Locked

  2. Series A

    Oct 19, 2021

    Amount

    $40M

    Investors

    Locked

  3. Series D

    Dec 7, 2010

    Amount

    $11M

    Investors

    Locked

  4. Series C

    Nov 11, 2008

    Amount

    $35M

    Investors

    Locked

  5. Series B

    Aug 16, 2006

    Amount

    $7.5M

    Investors

    Locked

  6. Series A

    Sep 16, 2004

    Amount

    $6M

    Investors

    Locked

Questions about Cerecin Pte.

Who invested in Cerecin Pte.?

Cerecin Pte. has 15 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Cerecin Pte. raised?

Cerecin Pte. has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did Cerecin Pte. last raise money?

Cerecin Pte.'s most recent round on record is a Series B, in Aug 2022.

What does Cerecin Pte. do?

Cerecin Pte. is a biotechnology company.

Where is Cerecin Pte. headquartered?

Cerecin Pte. is headquartered in Singapore, Singapore.

Which VCs invest in companies like Cerecin Pte.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Cerecin Pte.'s stage. Their profiles are linked below.

Raising like Cerecin Pte.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.